Determining The Survival Rate of Follicular Lymphoma

This article looks at the survival rate for Follicular lymphoma (FL), an indolent cancer that typically strikes people in their 50s and older.

It is the second most commonly diagnosed B-cell non-Hodgkin's lymphoma, after diffuse large B-cell lymphoma. FL is regarded as a manageable disease that may or may not require treatment. Although manageable, FL is not considered curable.

Determining the Survival Rate

Follicular lymphoma is rarely a fatal disease; patients are far more likely to survive their lymphoma than succumb to it. However, FL can sometimes progress into a more aggressive form of lymphoma that will require more aggressive treatment.

In an effort to give patients and doctors alike a better idea of the prognosis of any one FL patient, a prognostic index was developed known as the Follicular Lymphoma International Prognostic Index (FLIPI).

The FLIPI index presents the following five adverse risk factors; a point is added for each factor if true:

  • Patient age is 60 or older
  • Patient's disease stage is III or IV
  • Patient's hemoglobin level is less than 12 g/dL
  • Patient's serum LDH level is greater than the ULN (upper limit of normal)
  • Patient's number of affected nodal sites is equal to or greater than 5

The following point groups are then used to determine risk groups and the survival rate:

[Number of factors: Risk group: Est. overall lymphoma survival]

  • 0-1: Low risk: Estimated overall lymphoma survival at 10 years: 70%
  • 2: Intermediate risk: Estimated overall lymphoma survival at 10 years: 50%
  • 3 or more: High risk: Estimated overall lymphoma survival at 10 years: 35%

Since first being introduced several years ago, the FLIPI risk groups and overall lymphoma survival rates have been validated by subsequent studies. However, it does have its limitations, and really should only be used by patients and doctors together in improving the treatment choices they make.

Sources

  • Solal-Celigny P et al. Follicular lymphoma international prognostic index. Blood. 2004 Sep 1;104(5):1258-65
  • Buske C et al. The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low- risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood. 2006 Sep 1;108(5):1504-8
  • Formica V et al. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients. Acta Haematol. 2009;122(4):193-9

Related Reading

Photo: Pexels

More Articles

More Articles

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...